Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report
Abstract
The author describes the case of a patient who received neuroleptics and antiparkinsonian medications for more than 7 years and whose tardive dyskinesia symptoms disappeared after trihexyphenidyl was discontinued. The case appears to support the hypothesis that there is a threshold effect of antiparkinsonian agents on tardive dyskinesia.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
